Leading the fight on diabetes and obesity
partnering for innovation
Novo Nordisk Alberta Diabetes Fund (NOVAD)
Novo Nordisk Canada Inc., in partnership with the University Hospital Foundation and the Government of Alberta announces the Novo Nordisk Alberta Diabetes Fund (NOVAD), a 3-year, $2.5 million fund to advance innovations long-term health outcomes, quality of life, and economic prosperity for Albertans living with diabetes and obesity.
The partnership focuses on three objectives:
Improving diabetes-obesity interventions and management in the community setting for the most vulnerable patients
Enhancing diabetes-obesity interventions and management for seniors, to support independent living
Improving acute care for patients presenting in hospital with diabetes
Current Competitions
Submission for LOIs for funding through NOVAD now closed for 2018/2019.
Inquiries:
Contact Judi Bahl
Director of Strategic Partnerships, University Hospital Foundation
NOVAD 2019 Competition Winners
Principal Investigator:
Dr. Diana Mager
Project Title:
Development of innovative home-based strategies for frailty prevention in the community in adults with Diabetes and Chronic Kidney Disease.
Principal Investigator:
Dr. Denise Campbell-Scherer
Project Title:
Addressing clinical and social determinants of health to advance obesity and diabetes prevention and management in vulnerable newcomer ethno-cultural communities.
Principal Investigator:
Dr. Padma Kaul
Project Title:
Examining social and clinical determinants of childhood obesity at the population level.
Total amount of funds awarded: $770,300
300,000
In 2016 – 300,000 Albertans or 7.5% of the population were known to have diabetes.
1 in 5
1 in 5 hospital admissions in Canada will be a person living with diabetes.
$2,500,000
Amount invested to advance the long term health of Albertans living with obesity and diabetes.
Areas of Focus
Social and Clinical Determinants of Diabetes-Obesity
Improve diabetes-obesity interventions and management in the community setting for the most vulnerable patients who are living with diabetes and obesity. Design and apply health innovations to these populations in a select primary care network in Alberta.
Healthy Aging in Community Setting
Through Alberta health based innovations, enhance diabetes-obesity interventions and management for seniors to help support independent living and delayed care utilization.
Improving Acute Care Initiative
In Canada, roughly 1 in 5 hospital admissions will be a person living with diabetes, with around 40% of these patients on insulin. Through this focus, Alberta based innovations would be used to achieve consistent, safe blood glucose control as measured by A1c –and other improved health outcomes.
News & Announcements
About the Partners
Novo Nordisk Canada Inc.
Novo Nordisk Canada Inc. is an affiliate of Novo Nordisk A/S, a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: hemophilia, growth disorders and obesity.
University Hospital Foundation
Through donor support, the University Hospital Foundation provides funding that allows our medical teams at the University of Alberta Hospitals to remain on the forefront of medical advancements, keeping pace with constantly changing technology, emerging patient needs, and the latest knowledge and research discoveries.
Christy Holtby
Vice President, Strategic Partnerships
christy.holtby@ahs.ca
Ministry of Economic Development, Trade and Tourism
The Ministry of Alberta Economic Development, Trade and Tourism focuses on economic growth and diversification by supporting innovation and research; expanding access to capital for small and medium-sized enterprises; promoting trade, investment and market access initiatives; and leading Alberta’s negotiations on trade agreements.
University Hospital Foundation
Phone: 780-407-7007
Fax: 780-407-6603
uhfoundation@albertahealthservices.ca
Charitable Registration Number: 88900-3240 RR0001